According to reports out of Taiwan, due to the COVID-19 pandemic ravaging the world, TSMC has postponed its 3nm (nanometer) trial production. The company had to postpone the trial production after the pandemic affected its logistics and equipment supply chain. According to the company, it will extend its June installation schedule to October. Furthermore, its Nanke 18 plant trial production line may be delayed by at least one quarter.
In the supply chain assessment, TSMC originally planned to trial-produce the 3nm process at the end of this year. However, with the new development, it will also postpone it until early next year. Nevertheless, there are reports that TSMC would still mass-produce the 3nm process in 2022. The company has about two years to plan for the mass production.
As of now, we do not know the details of the 3nm process. This information was to come at the North American Technology Forum on April 29. However, like every other major conference globally, this conference has shifted to August 24. If all goes according to plan, we will know what the 3nm process offers in a few months.
Samsung will battle TSMC in the 3nm field
In the 3nm process, TSMC faces competition from Samsung Electronics. Samsung’s leader, Lee Jae-Hyun, said earlier that the company plans to use the latest 3-nanometer gate-all-around (GAA) process technology under development to manufacture cutting-edge chips and provide them to customers worldwide.
Founded in 1987, TSMC is the world’s largest semiconductor manufacturer specializing in wafer processing. Its customers include Apple, Qualcomm, Huawei, and others. Its headquarters is located in Hsinchu Science and Technology Industrial Park, Hsinchu, Taiwan. TSMC’s stock is listed on the Taiwan Stock Exchange with a stock code of 2330. In addition, it is also listed by the American Depositary Receipts on the New York Stock Exchange and the stock code is TSM. At the close of business on Thursday, TSMC rose 3.48% to $ 48.13, with a total market value of about $ 249.606 billion.